Critical Path Innovation Meeting with the FDA (20 October 2015)

CANCER-ID had the unique chance to have a Critical Path Innovation Meeting (CPIM) with representatives of the FDA in order to discuss regulatory aspects of CTC, ctDNA and miRNA based companion diagnostic development.

For more information about CPIM please click here.

Back

EUROPA - NEWS

What's new in Health and Life Sciences? Click here for news from the European Commission.

News Section

Vestec by Prague, Czech Republic

5th - 6th of June, 2019

Critical Path Innovation Meeting with the FDA (20 October 2015)

EUROPA - NEWS

News Section

Courses offered by TATAA Biocenter

Social Media